Literature DB >> 16189145

Chemokines in inflammatory bowel disease.

S Danese1, A Gasbarrini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16189145      PMCID： PMC1770732          DOI： 10.1136/jcp.2005.030916

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  25 in total

Review 1.  Multi-faceted strategies to combat disease by interference with the chemokine system.

Authors:  Zoë Johnson; Matthias Schwarz; Christine A Power; Timothy N C Wells; Amanda E I Proudfoot
Journal:  Trends Immunol       Date:  2005-05       Impact factor: 16.687

Review 2.  Inflammatory bowel disease: etiology and pathogenesis.

Authors:  C Fiocchi
Journal:  Gastroenterology       Date:  1998-07       Impact factor: 22.682

Review 3.  Chemokines and leukocyte traffic.

Authors:  M Baggiolini
Journal:  Nature       Date:  1998-04-09       Impact factor: 49.962

Review 4.  The central role of chemokines (chemotactic cytokines) in the immunopathogenesis of ulcerative colitis and Crohn's disease.

Authors:  R P MacDermott; I R Sanderson; H C Reinecker
Journal:  Inflamm Bowel Dis       Date:  1998-02       Impact factor: 5.325

5.  The C-X-C chemokine ENA-78 is preferentially expressed in intestinal epithelium in inflammatory bowel disease.

Authors:  K Z'Graggen; A Walz; L Mazzucchelli; R M Strieter; C Mueller
Journal:  Gastroenterology       Date:  1997-09       Impact factor: 22.682

6.  Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis.

Authors:  M Uguccioni; P Gionchetti; D F Robbiani; F Rizzello; S Peruzzo; M Campieri; M Baggiolini
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

7.  Increased interleukin-8 (IL-8) in rectal dialysate from patients with ulcerative colitis: evidence for a biological role for IL-8 in inflammation of the colon.

Authors:  A Keshavarzian; R D Fusunyan; M Jacyno; D Winship; R P MacDermott; I R Sanderson
Journal:  Am J Gastroenterol       Date:  1999-03       Impact factor: 10.864

8.  Accumulation of CCR5+ T cells around RANTES+ granulomas in Crohn's disease: a pivotal site of Th1-shifted immune response?

Authors:  Motoji Oki; Haruo Ohtani; Yoshitaka Kinouchi; Eiichi Sato; Shiro Nakamura; Takayuki Matsumoto; Hiroshi Nagura; Osamu Yoshie; Tooru Shimosegawa
Journal:  Lab Invest       Date:  2005-01       Impact factor: 5.662

Review 9.  Is secondary lymphoid-organ chemokine (SLC/CCL21) much more than a constitutive chemokine?

Authors:  H M Serra; C E Baena-Cagnani; Y Eberhard
Journal:  Allergy       Date:  2004-11       Impact factor: 13.146

Review 10.  Chemokines.

Authors:  Kerry J Laing; Christopher J Secombes
Journal:  Dev Comp Immunol       Date:  2004-05-03       Impact factor: 3.636
View more
  20 in total

Review 1.  Do we really understand what the immunological disturbances in inflammatory bowel disease mean?

Authors:  Epameinondas V Tsianos; Konstantinos Katsanos
Journal:  World J Gastroenterol       Date:  2009-02-07       Impact factor: 5.742

Review 2.  Role of genetics in the diagnosis and prognosis of Crohn's disease.

Authors:  Epameinondas V Tsianos; Konstantinos H Katsanos; Vasileios E Tsianos
Journal:  World J Gastroenterol       Date:  2011-12-28       Impact factor: 5.742

3.  Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice.

Authors:  R Ito; M Shin-Ya; T Kishida; A Urano; R Takada; J Sakagami; J Imanishi; M Kita; Y Ueda; Y Iwakura; K Kataoka; T Okanoue; O Mazda
Journal:  Clin Exp Immunol       Date:  2006-11       Impact factor: 4.330

4.  Metformin exerts anti-inflammatory effects on mouse colon smooth muscle cells in vitro.

Authors:  Ahmed Al-Dwairi; Mohammad Alqudah; Othman Al-Shboul; Mahmoud Alfaqih; Dana Alomari
Journal:  Exp Ther Med       Date:  2018-05-25       Impact factor: 2.447

5.  L13a-dependent translational control in macrophages limits the pathogenesis of colitis.

Authors:  Darshana Poddar; Ravinder Kaur; William M Baldwin; Barsanjit Mazumder
Journal:  Cell Mol Immunol       Date:  2015-07-13       Impact factor: 11.530

Review 6.  Role of genetics in the diagnosis and prognosis of Crohn's disease.

Authors:  Epameinondas V Tsianos; Konstantinos H Katsanos; Vasileios E Tsianos
Journal:  World J Gastroenterol       Date:  2012-01-14       Impact factor: 5.742

Review 7.  The role of chemokines in intestinal inflammation and cancer.

Authors:  Dingzhi Wang; Raymond N Dubois; Ann Richmond
Journal:  Curr Opin Pharmacol       Date:  2009-09-04       Impact factor: 5.547

Review 8.  Chemotaxis, chemokine receptors and human disease.

Authors:  Tian Jin; Xuehua Xu; Dale Hereld
Journal:  Cytokine       Date:  2008-08-21       Impact factor: 3.861

9.  Epithelial RABGEF1 deficiency promotes intestinal inflammation by dysregulating intrinsic MYD88-dependent innate signaling.

Authors:  Sophie El Abbas; Coraline Radermecker; Qiang Bai; Charline Beguin; Joey Schyns; Margot Meunier; Dimitri Pirottin; Christophe J Desmet; Marie-Alice Meuwis; Tatiana Art; Edouard Louis; See-Ying Tam; Mindy Tsai; Fabrice Bureau; Stephen J Galli; Thomas Marichal
Journal:  Mucosal Immunol       Date:  2019-10-18       Impact factor: 7.313

10.  Examination of structure-activity relationship of viologen-based dendrimers as CXCR4 antagonists and gene carriers.

Authors:  Jing Li; Ana-Maria Lepadatu; Yu Zhu; Marius Ciobanu; Yan Wang; Simona C Asaftei; David Oupický
Journal:  Bioconjug Chem       Date:  2014-05-12       Impact factor: 4.774
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.